Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: The AVOCADO study
Marek Rosiak, Marek Postula, Agnieszka Kaplon-Cieslicka, Agnieszka Kondracka, Ewa Trzepla, Andrzej Czlonkowski, Piotr K. Janicki, Krzysztof J. Filipiak, Grzegorz Opolski
Dive into the research topics of 'Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: The AVOCADO study'. Together they form a unique fingerprint.